HEMOGENYX PHARMACEUTICALS
Last Updated: 12/12/2025 07:30 PM
SHARE PRICE
590.00
CHANGE
-2.00 ( -0.35%) >
TICKER
HEMO.L
Share Chart
Latest Articles for HEMO.L
Hemogenyx secures clearance for pediatric enrolment in leukemia trial
October 6th, 2025
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment....
EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx
September 30th, 2025
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:...
Hemogenyx says exploring commercialisation of treatment for leukaemia
September 23rd, 2025
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell therapy company. ...
Hemogenyx shares jump as third patient treated for leukaemia form
September 17th, 2025
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. ...